ICU Medical PE Ratio 2010-2025 | ICUI
Current and historical p/e ratio for ICU Medical (ICUI) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. ICU Medical PE ratio as of July 30, 2025 is 22.77.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| ICU Medical PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-30 | 125.47 | 0.00 | |
| 2025-03-31 | 138.86 | $-3.83 | 0.00 |
| 2024-12-31 | 155.17 | $-4.83 | 0.00 |
| 2024-09-30 | 182.22 | $-4.57 | 0.00 |
| 2024-06-30 | 118.75 | $-2.92 | 0.00 |
| 2024-03-31 | 107.32 | $-2.45 | 0.00 |
| 2023-12-31 | 99.74 | $-1.23 | 0.00 |
| 2023-09-30 | 119.01 | $-1.17 | 0.00 |
| 2023-06-30 | 178.19 | $-2.02 | 0.00 |
| 2023-03-31 | 164.96 | $-1.92 | 0.00 |
| 2022-12-31 | 157.48 | $-3.12 | 0.00 |
| 2022-09-30 | 150.60 | $-1.56 | 0.00 |
| 2022-06-30 | 164.39 | $0.42 | 391.40 |
| 2022-03-31 | 222.64 | $2.04 | 109.14 |
| 2021-12-31 | 237.34 | $4.74 | 50.07 |
| 2021-09-30 | 233.38 | $5.04 | 46.31 |
| 2021-06-30 | 205.80 | $4.77 | 43.14 |
| 2021-03-31 | 205.44 | $4.34 | 47.34 |
| 2020-12-31 | 214.49 | $4.03 | 53.22 |
| 2020-09-30 | 182.76 | $3.78 | 48.35 |
| 2020-06-30 | 184.31 | $3.86 | 47.75 |
| 2020-03-31 | 201.77 | $4.04 | 49.94 |
| 2019-12-31 | 187.12 | $4.70 | 39.81 |
| 2019-09-30 | 159.60 | $3.38 | 47.22 |
| 2019-06-30 | 251.91 | $2.15 | 117.17 |
| 2019-03-31 | 239.33 | $2.53 | 94.60 |
| 2018-12-31 | 229.63 | $1.32 | 173.96 |
| 2018-09-30 | 282.75 | $4.01 | 70.51 |
| 2018-06-30 | 293.65 | $4.01 | 73.23 |
| 2018-03-31 | 252.40 | $0.70 | 360.57 |
| 2017-12-31 | 216.00 | $3.33 | 64.86 |
| 2017-09-30 | 185.85 | $1.54 | 120.68 |
| 2017-06-30 | 172.50 | $2.62 | 65.84 |
| 2017-03-31 | 152.70 | $5.47 | 27.92 |
| 2016-12-31 | 147.35 | $3.57 | 41.27 |
| 2016-09-30 | 126.38 | $3.36 | 37.61 |
| 2016-06-30 | 112.75 | $3.25 | 34.69 |
| 2016-03-31 | 104.10 | $3.10 | 33.58 |
| 2015-12-31 | 112.78 | $2.74 | 41.16 |
| 2015-09-30 | 109.50 | $2.87 | 38.15 |
| 2015-06-30 | 95.66 | $2.31 | 41.41 |
| 2015-03-31 | 93.14 | $1.86 | 50.08 |
| 2014-12-31 | 81.90 | $1.69 | 48.46 |
| 2014-09-30 | 64.18 | $2.09 | 30.71 |
| 2014-06-30 | 60.81 | $2.39 | 25.44 |
| 2014-03-31 | 59.88 | $2.49 | 24.05 |
| 2013-12-31 | 63.71 | $2.64 | 24.13 |
| 2013-09-30 | 67.93 | $2.60 | 26.13 |
| 2013-06-30 | 72.06 | $2.70 | 26.69 |
| 2013-03-31 | 58.95 | $2.85 | 20.68 |
| 2012-12-31 | 60.93 | $2.80 | 21.76 |
| 2012-09-30 | 60.48 | $3.24 | 18.67 |
| 2012-06-30 | 53.38 | $3.07 | 17.39 |
| 2012-03-31 | 49.16 | $3.11 | 15.81 |
| 2011-12-31 | 45.00 | $3.15 | 14.29 |
| 2011-09-30 | 36.80 | $2.61 | 14.10 |
| 2011-06-30 | 43.70 | $2.61 | 16.74 |
| 2011-03-31 | 43.78 | $2.50 | 17.51 |
| 2010-12-31 | 36.50 | $2.23 | 16.37 |
| 2010-09-30 | 37.29 | $2.01 | 18.55 |
| 2010-06-30 | 32.17 | $1.78 | 18.07 |
| 2010-03-31 | 34.45 | $1.60 | 21.53 |
| 2009-12-31 | 36.44 | $1.77 | 20.59 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.088B | $2.382B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $223.656B | 26.24 |
| Stryker (SYK) | United States | $152.832B | 31.96 |
| EssilorLuxottica (ESLOY) | France | $137.378B | 0.00 |
| Medtronic (MDT) | Ireland | $117.532B | 16.66 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.462B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.306B | 24.72 |
| ResMed (RMD) | United States | $40.680B | 30.56 |
| Agilent Technologies (A) | United States | $33.534B | 21.86 |
| GE HealthCare Technologies (GEHC) | United States | $32.803B | 15.37 |
| Koninklijke Philips (PHG) | Netherlands | $25.816B | 17.08 |
| Terumo (TRUMY) | Japan | $25.125B | 32.63 |
| Insulet (PODD) | United States | $20.991B | 82.39 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.463B | 11.86 |
| Baxter (BAX) | United States | $14.395B | 10.75 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.547B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.805B | 23.68 |
| Lantheus Holdings (LNTH) | United States | $4.970B | 12.54 |
| Perrigo (PRGO) | Ireland | $3.781B | 9.58 |
| Prestige Consumer Healthcare (PBH) | United States | $3.713B | 16.58 |
| Haemonetics (HAE) | United States | $3.644B | 16.60 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.383B | 28.11 |
| LeMaitre Vascular (LMAT) | United States | $1.852B | 41.40 |
| AtriCure (ATRC) | United States | $1.739B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.643B | 11.30 |
| Acuren (TIC) | United States | $1.391B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.271B | 28.60 |
| AdaptHealth (AHCO) | United States | $1.232B | 12.51 |
| Phibro Animal Health (PAHC) | United States | $1.132B | 14.47 |
| Neogen (NEOG) | United States | $1.019B | 16.19 |
| Curaleaf Holdings (CURLF) | Canada | $0.939B | 0.00 |
| InMode (INMD) | Israel | $0.879B | 8.13 |
| Kestra Medical Technologies (KMTS) | United States | $0.856B | 0.00 |
| Valneva SE (VALN) | France | $0.651B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.616B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.614B | 0.00 |
| Evolus (EOLS) | United States | $0.578B | 0.00 |
| Owens & Minor (OMI) | United States | $0.549B | 4.56 |
| CeriBell (CBLL) | United States | $0.539B | 0.00 |
| Surmodics (SRDX) | United States | $0.535B | 0.00 |
| ZimVie (ZIMV) | United States | $0.526B | 20.52 |
| SNDL (SNDL) | Canada | $0.378B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.342B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.315B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.308B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.307B | 11.29 |
| Quanterix (QTRX) | United States | $0.304B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.254B | 75.33 |
| Cerus (CERS) | United States | $0.250B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.244B | 20.60 |
| OraSure Technologies (OSUR) | United States | $0.239B | 0.00 |
| Omeros (OMER) | United States | $0.238B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.223B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.215B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.215B | 0.00 |
| Exagen (XGN) | United States | $0.190B | 0.00 |
| Organigram Global (OGI) | Canada | $0.184B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.07 |
| Vireo Growth (VREOF) | United States | $0.177B | 0.00 |
| High Tide (HITI) | Canada | $0.172B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.131B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.117B | 14.37 |
| Jushi Holdings (JUSHF) | United States | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.098B | 12.62 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.096B | 0.00 |
| Safety Shot (SHOT) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| Apyx Medical (APYX) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.064B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.058B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Nephros (NEPH) | United States | $0.037B | 50.43 |
| United-Guardian (UG) | United States | $0.036B | 12.51 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |